FAREVA Selects TraceLink to Comply with EU FMD Regulations
TraceLink Inc., the World’s Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, today announced that FAREVA has selected TraceLink’s serialization solutions to ensure compliance with the EU Falsified Medicines Directive (FMD). TraceLink and FAREVA will be at CPhI Worldwide, October 9 – 11 in Madrid, partnering together to provide education around EU FMD readiness and serialization.
A global pharmaceutical and API leading contract development and manufacturing organization (CDMO), FAREVA produces various dosage forms and API as well as offers packing options. With over 1,000 customers, FAREVA operates 35 sites across Europe, Russia, Turkey and The Americas.
As a leading global CDMO, FAREVA needed a serialization solution that could not only ensure compliance ahead of the February 2019 deadline, but one that enabled successful data exchange. TraceLink was selected because of its network-tenant platform and its proven ability to facilitate fast and comprehensive integration to CDMOs, allowing FAREVA to connect with its pharmaceutical customers.
“Serialization impacts every aspect of the pharmaceutical supply chain, and as a CDMO, we recognize the critical role we play in regard to industry preparedness. After a thorough evaluation, TraceLink stood out as the only provider who had a solution that would eliminate the time-intensive and cost prohibitive task of point-to-point connections, while also allowing us to streamline data exchange with our customers and support them in being compliant with serialization regulations,” said Sebastien Poncet, Vice-President of Sales at FAREVA.
More than 500 CMOs are fully-configured on the TraceLink Life Sciences Cloud and ready to exchange serialization data.
Visit TraceLink and FAREVA at CPhI Worldwide October 9-11, 2018 in Madrid. To learn more about how to work with both TraceLink and FAREVA to become EU FMD compliant, stop by stand 3C30.